Cargando…
Regulation of neural responses to emotion perception by ketamine in individuals with treatment-resistant major depressive disorder
The glutamate N-methyl-D-aspartate receptor antagonist ketamine has demonstrated antidepressant effects in individuals with treatment-resistant major depressive disorder (TRD) within 24 h of a single dose. The current study utilized functional magnetic resonance imaging (fMRI) and two separate emoti...
Autores principales: | Murrough, J W, Collins, K A, Fields, J, DeWilde, K E, Phillips, M L, Mathew, S J, Wong, E, Tang, C Y, Charney, D S, Iosifescu, D V |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4445748/ https://www.ncbi.nlm.nih.gov/pubmed/25689570 http://dx.doi.org/10.1038/tp.2015.10 |
Ejemplares similares
-
Altered peripheral immune profiles in treatment-resistant depression: response to ketamine and prediction of treatment outcome
por: Kiraly, D D, et al.
Publicado: (2017) -
Ketamine as a prophylactic resilience-enhancing agent
por: Evers, Audrey G., et al.
Publicado: (2022) -
A randomized, controlled pilot trial of the Emotional Faces Memory Task: a digital therapeutic for depression
por: Iacoviello, Brian M., et al.
Publicado: (2018) -
Initial Evidence for Brain Plasticity Following a Digital Therapeutic
Intervention for Depression
por: Hoch, Megan M., et al.
Publicado: (2019) -
Habenula Connectivity and Intravenous Ketamine in Treatment-Resistant Depression
por: Rivas-Grajales, Ana Maria, et al.
Publicado: (2020)